CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL

PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.

LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION

ITASCA,Ill.,March 6,2025-- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH),a U.S.-based cross-border supply chain solution provider with a unique focus on the

We Are Enough® Launches the 3.3.3 Challenge: A Global Movement Empowering Women Through Investing in Women

Venture Capitalist Tracy Gray Aims to Address Women\'s Wealth Gap and Access to Capital LOS ANGELES,March 6,2025-- We Are Enough (WAE),a nonprofit,launches the first of its kind initiative,the 3.3.3C

Beyond Music Acquires Copyright Stake in BTS Hit Song "Butter"

SEOUL,South Korea,March 5,2025-- Beyond Music,Asia\'s leading music intellectual properties (IPs) investment and data management company,has acquired a copyright stake in "Butter," the globa

China Unicom open the new 5G-A era

China Unicom Unveils AI Home Cloud and the “Tone” Agent at MWC in Barcelona Ushering in a New Chapter